V. Heilmann
- Oncology top 10%
- Cancer Treatment and Pharmacology 12
- HER2/EGFR in Cancer Research 5
- Colorectal Cancer Treatments and Studies 4
- Cancer Research top 10%
- Breast Cancer Treatment Studies 12
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments 4
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 3
-
- Cervical Cancer and HPV Research 4
-
- Molecular Biology Techniques and Applications 3
- Co-authors
- R. KreienbergA. RieberThorsten KühnHans‐Juergen BrambsAndreas GabelmannPeter MelsheimerRuediger KlaesMagnus von Knebel Doeberitz
- Journals
- Journal of Clinical Oncology (5 papers)Annals of Oncology (2 papers)Annals of Surgical Oncology (2 papers)
- Partner nations
- GermanyAustriaSwitzerland
In The Last Decade
V. Heilmann
29 papers receiving 851 citations
Peers
Comparison fields: 5 of 70
- Oncology 342
- Cancer Research 186
- Obstetrics and Gynecology 92
- Reproductive Medicine 81
- Radiology, Nuclear Medicine and Imaging 209
Countries citing papers authored by V. Heilmann
This map shows the geographic impact of V. Heilmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Heilmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Heilmann more than expected).
Fields of papers citing papers by V. Heilmann
This network shows the impact of papers produced by V. Heilmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Heilmann. The network helps show where V. Heilmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside V. Heilmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 19 | |
| 2 | 2013 | 19 | |
| 3 | 2010 | 1 | |
| 4 | 2008 | 24 | |
| 5 | 2008 | 46 | |
| 6 | 2006 | 50 | |
| 7 | 2005 | 4 | |
| 8 | 2005 | 58 | |
| 9 | 2005 | 12 | |
| 10 | 2005 | 29 | |
| 11 | 2005 | 3 | |
| 12 | 2005 | 1 | |
| 13 | 2004 | 0 | |
| 14 | 2004 | 14 | |
| 15 | Progression of cervical carcinomas is associated with down-regulation of CD9 but strong local re-expression at sites of transendothelial invasion. | 2003 | 45 |
| 16 | 2003 | 2 | |
| 17 | 2002 | 169 | |
| 18 | 2002 | 118 | |
| 19 | 1999 | 4 | |
| 20 | 1994 | 20 |
About V. Heilmann
V. Heilmann is a scholar working on Cancer Research, Oncology and Obstetrics and Gynecology, having authored 32 papers that have together received 870 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (5 papers), Endometrial and Cervical Cancer Treatments (4 papers), Cervical Cancer and HPV Research (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Molecular Biology Techniques and Applications (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). The work is most often cited by research in Oncology (342 citations), Cancer Research (186 citations) and Obstetrics and Gynecology (92 citations). V. Heilmann has collaborated with scholars based in Germany, Austria and Switzerland. Frequent co-authors include R. Kreienberg, A. Rieber, Thorsten Kühn, Hans‐Juergen Brambs, Andreas Gabelmann, Peter Melsheimer, Ruediger Klaes, Magnus von Knebel Doeberitz, Matthias Nees and Matthias Dürst. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Annals of Surgical Oncology, Journal of Cancer Research and Clinical Oncology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.